Study: A retrospective and prospective-cohort study to compare the immune response to Respiratory Syncytial Virus and clinical outcomes in patients who received nirsevimab versus those who did not receive nirsevimab in the prior respiratory season.
Thank you for expressing your interest in a research study and for taking the time to provide your information.
By clicking 'Submit', your information will be shared with the research team. Typically a member of the research team will contact you within 5 to 7 business days.
Please understand that:
Thanks again. Volunteers such as yourself are at the core of our work.